118 related articles for article (PubMed ID: 17069925)
1. Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system.
Laerm A; Helmbold P; Goldberg M; Dammann R; Holzhausen HJ; Ballhausen WG
J Hepatol; 2007 Jan; 46(1):89-97. PubMed ID: 17069925
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
3. Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies.
Nagai H; Li Y; Hatano S; Toshihito O; Yuge M; Ito E; Utsumi M; Saito H; Kinoshita T
Genes Chromosomes Cancer; 2003 Sep; 38(1):13-21. PubMed ID: 12874782
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter hypermethylation in biliary tract carcinoma.
Kohya N; Koga Y; Kitajima Y; Miyazaki K
J Hepatobiliary Pancreat Surg; 2006; 13(4):296-305. PubMed ID: 16858540
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.
Versmold B; Felsberg J; Mikeska T; Ehrentraut D; Köhler J; Hampl JA; Röhn G; Niederacher D; Betz B; Hellmich M; Pietsch T; Schmutzler RK; Waha A
Int J Cancer; 2007 Aug; 121(3):547-54. PubMed ID: 17415710
[TBL] [Abstract][Full Text] [Related]
7. A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma.
Shimoda M; Takahashi M; Yoshimoto T; Kono T; Ikai I; Kubo H
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6005-11. PubMed ID: 17062673
[TBL] [Abstract][Full Text] [Related]
8. Repression of interferon-gamma expression in T cells by Prospero-related homeobox protein.
Wang L; Zhu J; Shan S; Qin Y; Kong Y; Liu J; Wang Y; Xie Y
Cell Res; 2008 Sep; 18(9):911-20. PubMed ID: 19160541
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas.
Kishi M; Nakamura M; Nishimine M; Ikuta M; Kirita T; Konishi N
Oral Oncol; 2005 Feb; 41(2):161-9. PubMed ID: 15695118
[TBL] [Abstract][Full Text] [Related]
10. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
11. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract][Full Text] [Related]
12. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].
Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT
Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
14. The homeobox transcription factor Prox1 is highly conserved in embryonic hepatoblasts and in adult and transformed hepatocytes, but is absent from bile duct epithelium.
Dudas J; Papoutsi M; Hecht M; Elmaouhoub A; Saile B; Christ B; Tomarev SI; von Kaisenberg CS; Schweigerer L; Ramadori G; Wilting J
Anat Embryol (Berl); 2004 Aug; 208(5):359-66. PubMed ID: 15232737
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
17. Frequent inactivation of RUNX3 in endometrial carcinoma.
Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Wu Q; Lothe RA; Ahlquist T; Silins I; Tropé CG; Micci F; Nesland JM; Suo Z; Lind GE
Mol Cancer; 2007 Jul; 6():45. PubMed ID: 17623056
[TBL] [Abstract][Full Text] [Related]
19. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
20. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew M; Smith JL; Jass JR; Young J; Leggett BA; Macdonald GA
Oncol Rep; 2007 Apr; 17(4):817-22. PubMed ID: 17342321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
